ArticleActa pharmaceutica Sinica. B2023

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer.

Yubo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.